ATTO — Stock Film
STOCK FILMSCENE 1/10ATTO · $22.79
Stock Expert AI presents
ATTO
Attovia Therapeutics, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Attovia Therapeutics, Inc. What it actually does.

Provides customer relationship management (CRM) services. Offers business process outsourcing (BPO) solutions. Now — the numbers.

on the stock market since 2026
44 employees
$980.7M market value
Revenue last year:
$1.4M
The loss that same year:
$60.6M
For every $1 it earns, the company spends $46.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

In the vault right now:
$152.3M
DEBT: $5.3M
At this pace, that money lasts about 2.5 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
726.4×

This company is not turning a profit, so the market is pricing its sales instead: 726.4× for every dollar of annual revenue.

Against companies in its own sector, it looks cheaper than 41% of them.

Analysts' average target sits 99% above today's price.

What executives did with their own stock over the last 12 months:
17 buy6 sell

Executives buying with their own money is usually read as confidence in the company’s future.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
20
very weak

Clearly below the class average.

FINANCIAL STRENGTH
89
very strong

Debt is low and cash is strong; the finances stand solid.

VALUATION
41
weak

Clearly below the class average.

GROWTH
18
very weak

Clearly below the class average.

PRICE MOMENTUM
60
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Business Quality: Profit power and business quality trail similar companies in the sector.

1
THE BRIGHT SIDE · 1/3
The product is selling

Sales run at $1.4M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/3
Strong cash, light debt

There is $152.3M in the vault; even if every debt were paid off, $147.0M would remain.

3
THE BRIGHT SIDE · 3/3
Executives are buying their own stock

Over the last 12 months, company executives reported 17 buys and 6 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $60.6M against $1.4M in annual sales.

2
THE RISKS · 2/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 18/100.

3
THE RISKS · 3/3
The business trails its class

Measured against its sector, the quality of the business sits below the class average. Report-card grade: 20/100.

FINALE · THE GRADE
D
31 / 100 · MoonshotScore

On our five-subject report card, ATTO sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: ATTO is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

Analysts’ average target sits above today’s price, yet the valuation grade (41/100) says the stock isn’t cheap.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: the growth trend, earnings execution, the revenue breakdown, the price history.

This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film